Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

• Hoofdauteurs: Zhen Zeng (Auteur), Hao Lin (Auteur), Mingshan Jiang (Auteur), Jing Yuan (Auteur), Xi Li (Auteur), Yongbin Jia (Auteur), Li Yang (Auteur), Hu Zhang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The introduction of anti-tumor necrosis factor α (TNFα) biologics significantly innovated inflammatory bowel disease (IBD) treatment and increased medical costs. The recent expiration of patents of some anti-TNFα biologics (such as infliximab and adalimumab) facilitated the development of biosimilar...